While our current study does not directly address the local effects of hepatic FABP4, we believe we have comprehensively demonstrated the impact of adipose tissue–derived FABP4 on HCC cells, providing insights into HCC pathogenesis, particularly within the context of obesity. The gene discussed is FABP4; the disease is obesity disorder.